Uncovering plague’s survival secrets at ECU
- Roger Pechous, associate professor of microbiology and immunology in the Brody School of Medicine, received a $223,957 award from the National Institute of Allergy and Infectious Diseases.
- The project runs from Sept. 2, 2026, through Aug. 31, 2028, and is his second NIAID award this year.
- The work centers on a bacterial protein called BipA, which Pechous first linked to pneumonic plague in a 2021 paper in Infection and Immunity.
Why can the immune system stop so many bacteria but struggle against the one that causes plague?
That question drives East Carolina University researcher Roger Pechous, whose latest federally funded project examines a protein that helps plague bacteria survive inside the lungs.
Pechous, an associate professor of microbiology and immunology in ECU’s Brody School of Medicine, received an award from the National Institute of Allergy and Infectious Diseases providing $223,957 in direct costs to investigate how the protein BipA helps Yersinia pestis, the bacterium that causes plague, survive in the lungs.
The project runs through Aug. 31, 2028, and marks his second award from the institute this year.
“The protein I am working with is like a switch for the bacteria,” Pechous said.

A new award providing $223,957 in direct costs from the National Institute of Allergy and Infectious Diseases will support Roger Pechous’ investigation into how plague bacteria survive in the lungs.
When the bacteria encounter stressful conditions in the lungs, BipA helps direct which proteins they produce to survive. Pechous wants to identify those proteins and determine how they help the bacteria withstand the immune system.
The project builds on findings Pechous and his colleagues published in Infection and Immunity in 2021 showing that BipA helps plague bacteria survive in the lungs and cause disease.
By studying what happens when the switch is turned off, his team hopes to identify weaknesses that future treatments could target.
“This work identifies a protein that could be a target for therapeutic intervention,” Pechous said.
Although plague is often associated with the black death, a 14th century epidemic, Pechous said studying the bacterium has implications beyond its place in history. Other disease-causing bacteria use some of the same strategies to survive and evade immune defenses. Understanding those strategies in Yersinia pestis could help researchers better understand other infections.
Pneumonic plague affects the lungs and can develop after a person inhales respiratory droplets containing the bacteria. Its danger comes partly from how effectively the bacteria interfere with the body’s initial defenses, allowing an infection to advance before the immune system mounts a strong response.
“You have cells of your immune system patrolling your lungs ready to eliminate any virus, bacteria or fungus you breathe in,” Pechous said.
He explained that Yersinia pestis disrupts those cells’ ability to kill bacteria and call for help. The bacteria then multiply while the body’s early response remains limited.
When the immune system recognizes the infection, it sends large numbers of cells into the lungs. That response can damage lung tissue and impair breathing.
The new project examines how BipA helps the bacteria establish themselves during infection. Researchers hope to determine which proteins it activates and which immune defenses those proteins help the bacteria withstand.
The focus differs from Pechous’ earlier $226,500 award from the institute, which examined how competition for zinc between the bacteria and their mammalian host affects disease. Together, the projects approach a larger question from different directions, asking what allows the bacteria to survive inside the body.
The funding also creates opportunities for research training at ECU. A faculty member and two doctoral students will assist with the project, gaining experience with animal infection models and techniques for studying DNA, RNA and proteins.
The award will support salaries, student stipends and laboratory supplies needed to conduct the research.
For Pechous, the work begins with fundamental questions about why the immune system can control so many bacteria but struggles against this one. Answering those questions could help lay the groundwork for future treatments.
“I am motivated by curiosity and the hope that the information I add to the literature can contribute to our understanding of how pathogens cause disease, and how we might better manage and treat infections.”
More Stories